z-logo
Premium
New anti‐tumor agents. 1 . Heterocyclic benzodioxole lactones
Author(s) -
Jurd Leonard
Publication year - 1996
Publication title -
journal of heterocyclic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 59
eISSN - 1943-5193
pISSN - 0022-152X
DOI - 10.1002/jhet.5570330438
Subject(s) - chemistry , lactone , acetylation , yield (engineering) , acetic acid , alkylation , in vitro , methanol , methylation , sesamol , organic chemistry , aqueous solution , stereochemistry , biochemistry , dna , catalysis , antioxidant , materials science , metallurgy , gene
Morpholino Mannich bases of types 5, 12 react with tetronic acid in aqueous acetic acid to yield uncyclized lactones of types 7, 13 . Acetylation and methylation of these products yields monoacetyl‐monomethyl derivatives which can then be cyclized in alkali to give unsaturated lactones of types 8, 16 and saturated lactones 9b, 15 . The hydroxylactone 9a can be synthesized directly by reaction of 3,4,5‐trimethoxybenzaldehyde with sesamol and tetronic acid in methanol. With few exceptions the lactones of type 8 and 16 have proven to be active inhibitors of tumor growth in the National Cancer Institute in vitro screening program against 60 diverse human cancer cell lines. The lactone 8 is particularly potent, inhibiting in vitro growth of some cancers at concentrations as low as 10 −6 ‐10 −7 moles/1.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom